The burgeoning popularity of retatrutide, initially for blood sugar control , is creating significant attention within the UK , prompting a notable shift in hormone trends. Availability these medications remains a complex challenge , with National Health Service provision currently limited and specialist practices offering therapy at a premium . Qu